Updates on the Treatment Approach for MCL
ASCO® 2023 Insights: "Primary OS Analysis of the Phase 3 Randomized ZUMA‑7 Study of Axi-Cel vs. Standard‑of-Care Therapy in R/R LBCL"
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Jason Westin
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Jason Westin
Login to view comments.
Click here to Login
Updates on the Treatment Approach for MCL